Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Pfizer announces approval of tofacitinib for treatment of rheumatoid arthritis

Pfizer Inc. announced today that tofacitinib has been approved for the treatment of rheumatoid arthritis in patients who had an inadequate response to existing therapies in several additional countries around the world, including Switzerland, which is the first European country to receive approval.

15 Jul 2013

Robert H. Lurie Comprehensive Cancer Center receive highest rating

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its highest rating, an overall "outstanding," on the competitive renewal of its National Cancer Institute Cancer Center Support Grant, along with recommended funding of $24.9 million over the next five years.

15 Jul 2013

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and BZL Biologics LLC, of New York, today announced an exclusive licensing and collaboration agreement for an antibody against PSMA-positive prostate cancers.

15 Jul 2013

Actavis receives FDA approval for Opana ER tablets

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg.

15 Jul 2013

Childhood cancer survivors can still get pregnant despite increased risk of infertility

Although women who survived childhood cancer face an increased risk of infertility, nearly two-thirds of those who tried unsuccessfully to become pregnant for at least a year eventually conceived, according to clinical researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Brigham and Women's Hospital. This is comparable to the rate of eventual pregnancy among all clinically infertile women.

15 Jul 2013

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.

From QIAGEN Manchester Limited 15 Jul 2013

Ipsen closes acquisition of UK-based Syntaxin

Ipsen announced today the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering.

15 Jul 2013

Ipsen, Harvard initiate collaboration to discover, develop botulinum toxins for neurologic diseases

Ipsen announced today that it has initiated a research and development collaboration on novel engineered botulinum toxins with Harvard Medical School.

15 Jul 2013

HRC recognizes SCCA, UW Medicine hospitals as Leaders in LGBT Healthcare Equality

Today the Human Rights Campaign Foundation, the educational arm of the country's largest lesbian, gay, bisexual, and transgender organization, recognized Seattle Cancer Care Alliance and UW Medicine's four hospitals and as "Leaders in LGBT Healthcare Equality" in the Healthcare Equality Index 2013.

12 Jul 2013

Researchers find new potential treatment for cancer

A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way of killing cancer cells. The research, recently published in the journal Cell, has found a new potential treatment for cancer, which leaves the body's healthy cells undamaged, unlike traditional therapies such as radiotherapy.

12 Jul 2013

Antibodies boost immune system to fight childhood cancer, shows study

Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4. Each of these antibodies binds to a different target molecule in the immune system, potentially heightening the body's own immune response to cancer.

12 Jul 2013

Researchers to study effectiveness of palliative care home health visits for people with HIV

Researchers at Case Western Reserve University's Frances Payne Bolton School of Nursing will assess how effective palliative care home health visits are in treating people with HIV and other chronic illnesses in a new four-year, $1.7-million study funded by the National Institute of Nursing Research.

12 Jul 2013

Global recruitment drive to bring best cancer experts to Manchester now underway

A global recruitment drive to bring 20 of the world's best cancer experts and their teams to Manchester, in the United Kingdom, is now underway.

From The University of Manchester 12 Jul 2013

Dr. Reddy's Laboratories launches Decitabine for Injection

Dr. Reddy's Laboratories announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen (Decitabine for Injection) in the US market on July 11, 2013, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Decitabine for Injection.

12 Jul 2013

New discovery may help doctors determine role of microchimerism in human diseases

Some people possess a small number of cells in their bodies that are not genetically their own; this condition is known as microchimerism. It is difficult to determine potential health effects from this condition because of humans' relatively long life-spans.

12 Jul 2013

New discoveries about skin cancer

We've heard the warning many times before: wear sunscreen or cover up before going out into the sun. It's an alert worth paying attention to; the American Cancer Society expects 460 new cases to be diagnosed in 2013 in New Mexico alone. Now Marianne Berwick, PhD, and her international team of melanoma researchers support these warnings with some interesting discoveries about skin cancer.

11 Jul 2013

New study evaluates effectiveness of radioimmunotherapy in lymphoma patients

A new treatment option for patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas has been determined safe and feasible by researchers exploring the potential of a low energy beta-emitter radiopharmaceutical.

11 Jul 2013

Prolonged exposure to low levels of air pollution boosts lung cancer risk

Prolonged exposure to particulate air pollution increases the risk of lung cancer (particularly adenocarcinoma) even at levels below the European Union limit values, according to one of the largest studies of its kind published in The Lancet Oncology.

11 Jul 2013

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

The Nebraska Neuroscience Alliance at the University of Nebraska Medical Center, is embarking on a translational clinical trial using Leukine, a drug used to boost the immune system in cancer patients, to test a unique immune therapy in people with Parkinson's disease.

11 Jul 2013

Oncology News and Research

Further Reading

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Pfizer announces approval of tofacitinib for treatment of rheumatoid arthritis

Robert H. Lurie Comprehensive Cancer Center receive highest rating

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

Actavis receives FDA approval for Opana ER tablets

Childhood cancer survivors can still get pregnant despite increased risk of infertility

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

Ipsen closes acquisition of UK-based Syntaxin

Ipsen, Harvard initiate collaboration to discover, develop botulinum toxins for neurologic diseases

HRC recognizes SCCA, UW Medicine hospitals as Leaders in LGBT Healthcare Equality

Researchers find new potential treatment for cancer

Antibodies boost immune system to fight childhood cancer, shows study

Researchers to study effectiveness of palliative care home health visits for people with HIV

Global recruitment drive to bring best cancer experts to Manchester now underway

Dr. Reddy's Laboratories launches Decitabine for Injection

New discovery may help doctors determine role of microchimerism in human diseases

New discoveries about skin cancer

New study evaluates effectiveness of radioimmunotherapy in lymphoma patients

Prolonged exposure to low levels of air pollution boosts lung cancer risk

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News